February 24, 2022 Other Open Access

Meredith Smith; Serena Oliveri; Monica Casiraghi

Dublin Core Export

<?xml version='1.0' encoding='utf-8'?>
<oai_dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
  <dc:contributor>Rosanne Janssens</dc:contributor>
  <dc:contributor>Isabelle Huys</dc:contributor>
  <dc:contributor>Ian Smith</dc:contributor>
  <dc:contributor>Charis Girvalaki</dc:contributor>
  <dc:contributor>Ardine de Wit</dc:contributor>
  <dc:contributor>Jorien Veldwijk</dc:contributor>
  <dc:contributor>Lucilla Lanzoni</dc:contributor>
  <dc:creator>Meredith Smith</dc:creator>
  <dc:creator>Serena Oliveri</dc:creator>
  <dc:creator>Monica Casiraghi</dc:creator>
  <dc:date>2022-02-24</dc:date>
  <dc:description>We wanted to learn about lung cancer patients’ preferences for new treaments, and what they considered to be the maximum acceptable risk, and the minimum acceptable benefit of a treatment.</dc:description>
  <dc:identifier>https://zenodo.org/record/6260511</dc:identifier>
  <dc:identifier>10.5281/zenodo.6260511</dc:identifier>
  <dc:identifier>oai:zenodo.org:6260511</dc:identifier>
  <dc:relation>info:eu-repo/grantAgreement/EC/H2020/115966/</dc:relation>
  <dc:relation>doi:10.5281/zenodo.6260510</dc:relation>
  <dc:relation>url:https://zenodo.org/communities/prefer</dc:relation>
  <dc:rights>info:eu-repo/semantics/openAccess</dc:rights>
  <dc:rights>https://creativecommons.org/licenses/by/4.0/legalcode</dc:rights>
  <dc:subject>Plain language summary</dc:subject>
  <dc:subject>Case study</dc:subject>
  <dc:title>Treating non-small cell lung cancer: What do patients PREFER</dc:title>
  <dc:type>info:eu-repo/semantics/other</dc:type>
  <dc:type>other</dc:type>
</oai_dc:dc>